Horiba Instruments Inc recalls The ABX PENTRA Cholesterol CP ref. A11A01634 is an in vitro diagnostic assay for quantitative determination of choleste…
- Recall date
- January 11, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0738-2016
- FDA classification
- Class II
- Brand / firm
- Horiba Instruments Inc
- Sold / distributed
- U.S. distribution to the following; CA, NY, AL, OK, MN, MS, MD, TX, KY, WV, MT, IL, FL, VA, WA, MI, KS, NE, PA, OH, ID, OR, AR, AZ, NM, NC, SC, GA, TN No foreign distribution.
Why it was recalled
N-Acetylcysteine (NAC) present in the blood of patients treated for paracetamol overdose can interfere with the Trinder reaction that uses hydrogen peroxide catalytic on aminoantipyrine and phenol, and can produce falsely low results with the reagents using the Trinder reaction method.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
The ABX PENTRA Cholesterol CP ref. A11A01634 is an in vitro diagnostic assay for quantitative determination of cholesterol in human serum and plasma based on an enzymatic photometric test (Trinders reaction). The assay is composed of a 99 ml mono-reagent cassette. Reagent is a chemical solution with additives.
Get recall alerts
Free email alert whenever Horiba Instruments Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Horiba Instruments Inc